毕得医药大涨实控人提议回购

智选洞察11-26

11月26日，毕得医药（688073）股价大幅上涨，截至09点36分，毕得医药上涨5.14%，报45.20元/股，成交686万元，换手率0.36%，振幅4.19%。消息解读毕得医药实控人提议公司以0.5亿元至1亿元回购股份，此举基于对公司未来发展的信心和对公司价值的认可。提议回购股份的目的是为了进一步建立、健全公司长效激励机制，吸引和留住优秀人才，充分调动公司员工的积极性和创造性，并增强投资者对...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2486094433?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-11-26 09:36","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2486094433","market":"sh","top_or_hot":-1,"title":"毕得医药大涨 实控人提议回购","media":"智选洞察","content":"<div>\n<p>11月26日，毕得医药（688073）股价大幅上涨，截至09点36分，毕得医药上涨5.14%，报45.20元/股，成交686万元，换手率0.36%，振幅4.19%。消息解读毕得医药实控人提议公司以0.5亿元至1亿元回购股份，此举基于对公司未来发展的信心和对公司价值的认可。提议回购股份的目的是为了进一步建立、健全公司长效激励机制，吸引和留住优秀人才，充分调动公司员工的积极性和创造性，并增强投资者对...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126093650a255bc6f&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>毕得医药大涨 实控人提议回购</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n毕得医药大涨 实控人提议回购\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-26 09:36 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126093650a255bc6f&s=b><strong>智选洞察</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>11月26日，毕得医药（688073）股价大幅上涨，截至09点36分，毕得医药上涨5.14%，报45.20元/股，成交686万元，换手率0.36%，振幅4.19%。消息解读毕得医药实控人提议公司以0.5亿元至1亿元回购股份，此举基于对公司未来发展的信心和对公司价值的认可。提议回购股份的目的是为了进一步建立、健全公司长效激励机制，吸引和留住优秀人才，充分调动公司员工的积极性和创造性，并增强投资者对...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126093650a255bc6f&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0216","symbol_name":"研究试验","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126093650a255bc6f&s=b","article_id":"2486094433","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126093650a255bc6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2486094433","pubTimestamp":1732584974,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"11月26日，毕得医药股价大幅上涨，截至09点36分，毕得医药上涨5.14%，报45.20元/股，成交686万元，换手率0.36%，振幅4.19%。消息解读毕得医药实控人提议公司以0.5亿元至1亿元回购股份，此举基于对公司未来发展的信心和对公司价值的认可。资金动向截止发稿，毕得医药获得主力净流入65万元。最新财报显示，今年三季报，毕得医药实现营业收入8.11亿元，同比增长0.79%，净利润为8,385.39万元，同比减少26.05%，基本每股收益为0.94元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"688073":"毕得医药","BK0216":"研究试验"},"translate_title":"Bide Pharmaceutical surges, actual controller proposes repurchase","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688073":1},"content_text":"11月26日，毕得医药（688073）股价大幅上涨，截至09点36分，毕得医药上涨5.14%，报45.20元/股，成交686万元，换手率0.36%，振幅4.19%。消息解读毕得医药实控人提议公司以0.5亿元至1亿元回购股份，此举基于对公司未来发展的信心和对公司价值的认可。提议回购股份的目的是为了进一步建立、健全公司长效激励机制，吸引和留住优秀人才，充分调动公司员工的积极性和创造性，并增强投资者对公司的投资信心，紧密结合公司利益、股东利益与员工利益，促进公司健康可持续发展##此外，数据统计显示，近半年内3家券商给予增持建议，3家券商给予买入建议。资金动向截止发稿，毕得医药获得主力净流入65万元。数据显示，该股今日净流入较近5日净流入均值减少2万元。融资融券方面，毕得医药11月22日获得融资净买入126万元，当日该股融资余额为4935万元，当较前一日增加2.64%；该股融券余额为11万元，融券余量为0.25万股。主营业务及业绩毕得医药公司主营业务为聚焦于新药研发产业链前端，依托药物分子砌块的研发设计、生产及销售等核心业务，能够为新药研发机构提供结构新颖、功能多样的药物分子砌块及科学试剂等产品。最新财报显示，今年三季报，毕得医药实现营业收入8.11亿元，同比增长0.79%，净利润为8,385.39万元，同比减少26.05%，基本每股收益为0.94元。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2486094433"}

毕得医药大涨 实控人提议回购

精彩评论

毕得医药大涨实控人提议回购